Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma

<p>Immunologic pathway genes</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Alexander N. Shoushtari (15023909) (author)
Altres autors:	Anthony J. Olszanski (15031292) (author), Marta Nyakas (15051200) (author), Thomas J. Hornyak (15051203) (author), Jedd D. Wolchok (15032924) (author), Victor Levitsky (15051206) (author), Lukasz Kuryk (15051209) (author), Thomas B. Hansen (15051212) (author), Magnus Jäderberg (15051215) (author)
Publicat:	2025
Matèries:	Cancer Tumor Biology Clinical Research and Trials Clinical-Stage Research Skin Cancers Melanoma Tumor Microenvironment Immune cells and the microenvironment
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars